| Issue Date | Title | Author(s) |
| 2013-09-02 | Microparticles mediate MRP1 intercellular transfer and the re-templating of intrinsic resistance pathways | Lu, JF; Luk, F; Gong, J; Jaiswal, R; Grau, GER; Bebawy, M |
| 2011-01-01 | Modulation of P-glycoprotein-mediated anticancer drug accumulation, cytotoxicity, and ATPase activity by flavonoid interactions | Tran, VH; Marks, D; Duke, RK; Bebawy, M; Duke, CC; Roufogalis, BD |
| 2015-01-01 | Fabrication of curcumin micellar nanoparticles with enhanced anti-cancer activity | Lee, WH; Bebawy, M; Loo, CY; Luk, F; Mason, RS; Rohanizadeh, R |
| 2019-01 | Metformin: A Salutary Candidate for Colorectal Cancer Treatment in Patients with Diabetes. | Samuel, VP; Dahiya, R; Singh, Y; Gupta, G; Sah, SK; Gubbiyappa, SK; Chellappan, DK; Dua, K |
| 1999-03-15 | A continuous fluorescence assay for the study of p-glycoprotein-mediated drug efflux using inside-out membrane vesicles | Bebawy, M; Morris, MB; Roufogalis, BD |
| 2018-11-01 | Comparative efficacy and safety of tyrosine kinase inhibitors for chronic myeloid leukaemia: A systematic review and network meta-analysis | Fachi, MM; Tonin, FS; Leonart, LP; Aguiar, KS; Lenzi, L; Figueiredo, BC; Fernandez-Llimos, F; Pontarolo, R |
| 2014-01-01 | Inhibition of the multidrug resistance P-glycoprotein: Time for a change of strategy? | Callaghan, R; Luk, F; Bebawy, M |
| 2011-03-01 | Pectin matrix as oral drug delivery vehicle for colon cancer treatment | Wong, TW; Colombo, G; Sonvico, F |
| 2006-04-14 | The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells | Holland, ML; Panetta, JA; Hoskins, JM; Bebawy, M; Roufogalis, BD; Allen, JD; Arnold, JC |
| 2019-08-25 | Emerging trends in the novel drug delivery approaches for the treatment of lung cancer | Sharma, P; Mehta, M; Dhanjal, DS; Kaur, S; Gupta, G; Singh, H; Thangavelu, L; Rajeshkumar, S; Tambuwala, M; Bakshi, HA; Chellappan, DK; Dua, K; Satija, S |
